Correlation analysis between mammography features of early-stage invasive breast ductal carcinoma with positive ER, negative HER2, negative lymph node and Oncotype DX21 gene assay results
Background and purpose: The Oncotype DX21 gene assay holds great promise in prognostic prediction and adjuvant treatment decision-making, but the test samples obtained through invasive surgery can not completely represent the whole tumor. Mammography is a noninvasive, economical and simple routine e...
Main Author: | WANG Ting , LIU Zhuang , GONG Jing , JIANG Lin , SHEN Xigang , GU Yajia |
---|---|
Format: | Article |
Language: | English |
Published: |
Editorial Office of China Oncology
2021-06-01
|
Series: | Zhongguo aizheng zazhi |
Subjects: | |
Online Access: | http://www.china-oncology.com/fileup/1007-3639/PDF/20210605.pdf |
Similar Items
-
Clinicopathological Factors Associated with Oncotype DX Risk Group in Patients with ER+/HER2- Breast Cancer
by: Ran Song, et al.
Published: (2023-09-01) -
The Oncotype Dx Assay in ER-Positive, HER2-Negative Breast Cancer Patients: A Real Life Experience from a Single Cancer Center
by: Stephane Thibodeau, et al.
Published: (2019-07-01) -
Cost-Effectiveness Analysis of the Oncotype DX Breast Recurrence Score® Test in Node-Negative Early Breast Cancer
by: Berdunov V, et al.
Published: (2022-09-01) -
How Canadian Oncologists Use Oncotype DX for Treatment of Breast Cancer Patients
by: Xiaofu Zhu, et al.
Published: (2021-02-01) -
Survival results according to Oncotype Dx recurrence score in patients with hormone receptor positive HER-2 negative early-stage breast cancer: first multicenter Oncotype Dx recurrence score survival data of Turkey
by: Çağlar Ünal, et al.
Published: (2023-06-01)